Location History:
- Radnor, PA (US) (2014 - 2015)
- Spring House, PA (US) (2017 - 2018)
- Bridgewater, NJ (US) (2007 - 2022)
Company Filing History:
10 out of 410 
7 out of 122 
6 out of 4,770 
Years Active: 2007-2022
Title: William Strohl: A Trailblazer in Innovations and Patents
Introduction:
Throughout his illustrious career, William Strohl has continually impressed the industry with his exceptional creativity and ingenuity. Hailing from Bridgewater, NJ (US), Strohl's unwavering dedication to pushing technological boundaries and his commitment to improving lives have been the driving forces behind his remarkable success. In this article, we will delve into Strohl's latest patents, highlight key moments in his career, and explore his fruitful collaborations.
Latest Patents:
Strohl's latest patents showcase his ability to develop groundbreaking solutions that address pressing challenges. Two notable inventions are his "RAGE fusion proteins with improved stability and ligand binding affinity and uses thereof" patent and the "Chimeric antigen receptors comprising BCMA-specific fibronectin type III domains and uses thereof" patent.
The RAGE fusion protein invention provides soluble RAGE-Fc fusion proteins, which exhibit increased stability and an extended half-life. These proteins have a superior ability to bind endogenous RAGE ligands with high apparent affinity, making them valuable therapeutic options. Strohl's innovation has opened doors for advancements in treating various diseases.
The BCMA-specific fibronectin type III (FN3) domains patent introduces BCMA-targeting chimeric antigen receptors (CARs) incorporating FN3 domains. These CARs, along with specially engineered BCMA-targeting immune cells, hold great promise in the battle against cancer. Strohl's groundbreaking research has paved the way for new approaches to disease treatment.
Career Highlights:
Strohl's impressive career has been marked by numerous milestones and achievements. His 29 patents are a testament to his relentless pursuit of innovation. Establishing himself as a leader in his field, Strohl has made substantial contributions to renowned companies such as Janssen Biotech, Inc. and CSL Limited.
Collaborations:
Collaboration has been at the core of Strohl's success, with his work often benefiting from strategic alliances. Notably, he has collaborated with esteemed colleagues such as Zhiqiang An and Gene G Kinney. These partnerships have fostered an atmosphere of collective expertise, enabling Strohl to develop pioneering solutions.
Conclusion:
William Strohl's career exemplifies the spirit of innovation and inventiveness. His latest patents, such as the RAGE fusion proteins and BCMA-specific FN3 domains, demonstrate his ability to solve complex challenges with practical and groundbreaking solutions. Strohl's collaborations and contributions to esteemed companies have solidified his reputation as a trailblazer in the field of innovations and patents.
As an esteemed inventor, Strohl continues to push the boundaries of technology, all with the ultimate goal of enhancing the lives of people worldwide. His dedication and commitment to the advancement of science make him an influential figure in the industry, inspiring future generations of inventors and innovators.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.